We are live on ! Find out more
THP

Tower House Partners Portfolio holdings

AUM $16.8M
1-Year Est. Return 41.98%
This Fund
S&P 500
This Quarter Est. Return
+24.98%
1 Year Est. Return
-41.98%
3 Year Est. Return
+21.45%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$205M
AUM Growth
+$18.3M
Cap. Flow
-$24.4M
Cap. Flow %
-11.89%
Top 10 Hldgs %
100%
Holding
6
New
1
Increased
–
Reduced
4
Closed
1

Top Buys

Rank Stock Value
1
BLFS icon
BioLife Solutions
BLFS
+$16.1M

Top Sells

Rank Stock Value
1
AZTA icon
Azenta
AZTA
+$16.9M
2
BIO icon
Bio-Rad Laboratories Class A
BIO
+$8.54M
3
CTLT
CATALENT, INC.
CTLT
+$7.62M
4
CRL icon
Charles River Laboratories
CRL
+$5.44M
5
CYRX icon
CryoPort
CYRX
+$1.96M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
2 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AZTA icon
1
Azenta
AZTA
$1.21B
$51.5M 25.09%
758,339
-271,661
-26% -$16.9M
CRL icon
2
Charles River Laboratories
CRL
$10.8B
$46.8M 22.81%
187,138
-22,862
-11% -$5.44M
CTLT
3
DELISTED
CATALENT, INC.
CTLT
$44.2M 21.57%
425,000
-78,600
-16% -$7.62M
BIO icon
4
Bio-Rad Laboratories Class A
BIO
$8.15B
$43.7M 21.32%
75,000
-15,000
-17% -$8.54M
BLFS icon
5
BioLife Solutions
BLFS
$1.42B
$18.9M 9.2%
+473,100
New +$16.1M
CYRX icon
6
CryoPort
CYRX
$832M
– –
-41,279
Closed -$1.96M

Similar funds

RCGV
Ribbit Capital GP V Palo Alto, California $19.8M AUM
SCM
Stamina Capital Management New York $13.3M AUM 71.17% 1-Year Est. Return
CCA
Cross Creek Advisors Salt Lake City, Utah $20.5M AUM 54.22% 1-Year Est. Return
OHU
Odey Holdings (UK) London, United Kingdom $12.4M AUM 20.7% 1-Year Est. Return
OA
Oakhurst Advisors Los Angeles, California $21.3M AUM 8.8% 1-Year Est. Return
JM
Jeneq Management New York $22.3M AUM 47.87% 1-Year Est. Return
OP
Osmium Partners Greenbrae, California $10.4M AUM 73.79% 1-Year Est. Return
AC
Athanor Capital New York $24.6M AUM 2.49% 1-Year Est. Return

Tower House Partners's Q4 2020 Portfolio in Review

As of Q4 2020, Tower House Partners held 6 positions worth $205M, up 9.8% from $187M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Tower House Partners withdrew a net $24.4M in Q4 2020, closing 1 position and reducing 4 holdings. Its most notable exit was CryoPort, an estimated $1.96M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 99% a quarter earlier, followed by Industrials.

Against the trend, Tower House Partners opened a new position in BioLife Solutions worth $18.9M.

  • Tower House Partners's largest Q4 2020 buy was BioLife Solutions: 473,100 shares worth $18.9M.
  • Tower House Partners's biggest Q4 2020 reduction was Azenta, cutting an estimated $16.9M.
  • Tower House Partners fully exited CryoPort in Q4 2020, selling an estimated $1.96M.
  • Tower House Partners's ten largest holdings make up 100% of its $205M portfolio in Q4 2020.
  • Tower House Partners opened 1 new position and closed 1 in Q4 2020.
  • Tower House Partners's portfolio value rose 9.8% quarter-over-quarter to $205M.

Based on Tower House Partners's 13F filing for Q4 2020, filed 5 Mar 2021.